E-LIB Suche - Ergebnisse für: Bo, Yunxin Y.

1

Structure-Based Design of a Novel Series of Potent, Selecti..:

Smith, Adrian L. ; D'Angelo, Noel D. ; Bo, Yunxin Y....
Journal of Medicinal Chemistry. 55 (2012) 11 - p. 5188-5219 , 2012

Link: https://doi.org/10.1021/..

2

Selective Class I Phosphoinositide 3-Kinase Inhibitors: Opt..:

Norman, Mark H. ; Andrews, Kristin L. ; Bo, Yunxin Y....
Journal of Medicinal Chemistry. 55 (2012) 17 - p. 7796-7816 , 2012

Link: https://doi.org/10.1021/..

3

Correction to Selective Class I Phosphoinositide 3-Kinase I..:

Norman, Mark H. ; Andrews, Kristin L. ; Bo, Yunxin Y....
Journal of Medicinal Chemistry. 55 (2012) 20 - p. 8975-8975 , 2012

Link: https://doi.org/10.1021/..

4

The imidazo[1,2-a]pyridine ring system as a scaffold for po..:

Stec, Markian M. ; Andrews, Kristin L. ; Bo, Yunxin...
Bioorganic & Medicinal Chemistry Letters. 25 (2015) 19 - p. 4136-4142 , 2015

Link: https://doi.org/10.1016/..

5

Small Molecule Disruptors of the Glucokinase–Glucokinase Re..:

Tamayo, Nuria A. ; Norman, Mark H. ; Bartberger, Michael D....
Journal of Medicinal Chemistry. 58 (2015) 11 - p. 4462-4482 , 2015

Link: https://doi.org/10.1021/..

6

Optimization of Potency and Pharmacokinetic Properties of T..:

Horne, Daniel B. ; Tamayo, Nuria A. ; Bartberger, Michael D....
Journal of Medicinal Chemistry. 57 (2014) 7 - p. 2989-3004 , 2014

Link: https://doi.org/10.1021/..

7

Fused Piperidines as a Novel Class of Potent and Orally Ava..:

Tamayo, Nuria A. ; Bo, Yunxin ; Gore, Vijay...
Journal of Medicinal Chemistry. 55 (2012) 4 - p. 1593-1611 , 2012

Link: https://doi.org/10.1021/..

8

Synthesis and structure–activity relationships of dual PI3K..:

Wurz, Ryan P. ; Liu, Longbin ; Yang, Kevin...
Bioorganic & Medicinal Chemistry Letters. 22 (2012) 17 - p. 5714-5720 , 2012

Link: https://doi.org/10.1016/..

9

Phospshoinositide 3-Kinase (PI3K)/Mammalian Target of Rapam..:

Nishimura, Nobuko ; Siegmund, Aaron ; Liu, Longbin...
Journal of Medicinal Chemistry. 54 (2011) 13 - p. 4735-4751 , 2011

Link: https://doi.org/10.1021/..

10

Substituted aryl pyrimidines as potent and soluble TRPV1 an..:

Stec, Markian M. ; Bo, Yunxin ; Chakrabarti, Partha P....
Bioorganic & Medicinal Chemistry Letters. 18 (2008) 18 - p. 5118-5122 , 2008

Link: https://doi.org/10.1016/..

11

Novel Vanilloid Receptor-1 Antagonists: 1. Conformationall..:

Norman, Mark H. ; Zhu, Jiawang ; Fotsch, Christopher...
Journal of Medicinal Chemistry. 50 (2007) 15 - p. 3497-3514 , 2007

Link: https://doi.org/10.1021/..

12

Novel Vanilloid Receptor-1 Antagonists: 2. Structure−Activ..:

Doherty, Elizabeth M. ; Fotsch, Christopher ; Bannon, Anthony W....
Journal of Medicinal Chemistry. 50 (2007) 15 - p. 3515-3527 , 2007

Link: https://doi.org/10.1021/..

13

Design of Potent, Orally Available Antagonists of the Trans..:

Ognyanov, Vassil I. ; Balan, Chenera ; Bannon, Anthony W....
Journal of Medicinal Chemistry. 49 (2006) 12 - p. 3719-3742 , 2006

Link: https://doi.org/10.1021/..

14

Melanocortin subtype-4 receptor agonists containing a piper..:

Fotsch, Christopher ; Han, Nianhe ; Arasasingham, Premilla...
Bioorganic & Medicinal Chemistry Letters. 15 (2005) 6 - p. 1623-1627 , 2005

Link: https://doi.org/10.1016/..

15

Synthesis and evaluation of thiazole carboxamides as vanill..:

Xi, Ning ; Bo, Yunxin ; Doherty, Elizabeth M....
Bioorganic & Medicinal Chemistry Letters. 15 (2005) 23 - p. 5211-5217 , 2005

Link: https://doi.org/10.1016/..